Zobrazeno 1 - 10 of 116 pro vyhledávání: '"Persoons, V."'
1
Report
Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC).
Autor: Rafii H; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France. hanadi.rafii-elayoubi@aphp.fr.; Monacord, International Observatory on Sickle Cell Disease, Centre Scientifique de Monaco, Monaco, Monaco. hanadi.rafii-elayoubi@aphp.fr., Ionescu I; Agency of Biomedecine, La Plaine, Saint-Denis, France., Ruggeri A; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Garnier F; Agency of Biomedecine, La Plaine, Saint-Denis, France., Ballot C; Laboratoire de Thérapie Cellulaire, Etablissement Français du Sang Hauts de France Normandie, site de LILLE - Belfort, Lille, France., Bensoussan D; Tissue Engineering and Cell Therapy unit, Regional University hospital, Nancy, France., Chabannon C; Paoli-Calmettes Institute, Departement of Cancer Biology, Inserm CBT1409, Marseille, France., Dazey B; Cell Therapy unit, Etablissement Français du Sang, Bordeaux, France., De Vos J; Cell Therapy unit, University hospital, Montpellier, France., Gautier E; Cell Therapy unit, Etablissement Français du Sang, Créteil, France., Giraud C; Department of Hematology and Cell Therapy, Etablissement Français du Sang, University hospital, Poitiers, France., Larghero J; Cell Therapy Unit and Cord Blood Bank, AP-HP, Hôpital Saint Louis, 1 avenue Claude Vellefaux, F-75010, Paris, France., Cras A; Cell Therapy Unit and Cord Blood Bank, AP-HP, Hôpital Saint Louis, 1 avenue Claude Vellefaux, F-75010, Paris, France., Mialou V; Cell Therapy unit, Etablissement Français du Sang, hopital E. Herriot, Lyon, France., Persoons V; Cell Therapy and Tissue Engineering unit, Etablissement Français du Sang, Grenoble, France., Pouthier F; Cell and Tissue Engineering unit, Etablissement Francais du Sang, Besançon, France., Thibert JB; Cell Therapy unit, Etablissement Français du Sang, Rennes, France., Dalle JH; Hopital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France., Michel G; Aix-Marseille University and La Timone Children's Hospital, Marseille, France., Sinayoko M; Agency of Biomedecine, La Plaine, Saint-Denis, France., Kenzey C; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, International Observatory on Sickle Cell Disease, Centre Scientifique de Monaco, Monaco, Monaco., Volt F; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, International Observatory on Sickle Cell Disease, Centre Scientifique de Monaco, Monaco, Monaco., Rocha V; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Department of Hematology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil., Bay JO; Department of Hematology and Stem Cell Transplantation, Clermont University, Clermont-Ferrand, France., Rubio MT; Department of Hematology and Stem Cell Transplantation, regional university hospital, Nancy, France., Robin M; Department of Hematology and Stem Cell Transplantation, AP-HP, Hôpital Saint Louis, 1 avenue Claude Vellefaux, Paris, France., Faucher C; Agency of Biomedecine, La Plaine, Saint-Denis, France., Marry E; Agency of Biomedecine, La Plaine, Saint-Denis, France., Gluckman E; Eurocord, Hopital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, International Observatory on Sickle Cell Disease, Centre Scientifique de Monaco, Monaco, Monaco.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2022 Jan; Vol. 57 (1), pp. 125-127. Date of Electronic Publication: 2021 Oct 07.
Zobrazit plný text záznamu
2
Akademický článek
Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC).
Autor: Rafii H; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France. hanadi.rafii-elayoubi@aphp.fr.; Monacord, Centre Scientifique de Monaco, Monaco, Monaco. hanadi.rafii-elayoubi@aphp.fr., Garnier F; Agency of Biomedecine, Saint Denis La Plaine, France., Ruggeri A; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ionescu I; Agency of Biomedecine, Saint Denis La Plaine, France., Ballot C; Cell Therapy unit, Etablissement Français du Sang Hauts de France Normandie, site de LILLE - Belfort, Lille, France., Bensoussan D; Tissue Engineering and Cell Therapy unit, Regional University hospital, Nancy, France., Chabannon C; Paoli-Calmettes Institute, Departement of Cancer Biology, Inserm CBT1409, Marseille, France., Dazey B; Cell Therapy unit, Etablissement Français du Sang, Bordeaux, France., De Vos J; Cell Therapy unit, University hospital, Montpellier, France., Gautier E; Cell Therapy unit, Etablissement Français du Sang, Créteil, France., Giraud C; Department of Hematology and Cell Therapy, Etablissement Français du Sang, University hospital, Poitiers, France., Larghero J; Cell Therapy Unit and Cord Blood Bank, AP-HP, Hôpital Saint Louis, Paris, France., Cras A; Cell Therapy Unit and Cord Blood Bank, AP-HP, Hôpital Saint Louis, Paris, France., Mialou V; Cell Therapy unit, Etablissement Français du Sang, hopital E. Herriot, Lyon, France., Persoons V; Cell Therapy and Tissue Engineering unit, Etablissement Français du Sang, Grenoble, France., Pouthier F; Cell and Tissue Engineering unit, Etablissement Francais du Sang, Besançon, France., Thibert JB; Cell Therapy unit, Etablissement Français du Sang, Rennes, France., Dalle JH; Hopital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France., Michel G; Aix-Marseille University and La Timone Children's Hospital, Marseille, France., Kenzey C; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, Centre Scientifique de Monaco, Monaco, Monaco., Volt F; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, Centre Scientifique de Monaco, Monaco, Monaco., Rocha V; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Department of Hematology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil., Bay JO; Department of Hematology and Stem Cell Transplantation, Clermont University, Clermont-Ferrand, France., Rubio MT; Department of Hematology and Stem Cell Transplantation, regional university hospital, Nancy, France., Faucher C; Agency of Biomedecine, Saint Denis La Plaine, France., Marry E; Agency of Biomedecine, Saint Denis La Plaine, France., Gluckman E; Eurocord, Hopital Saint-Louis, AP-HP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris, Paris, France.; Monacord, Centre Scientifique de Monaco, Monaco, Monaco.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Oct; Vol. 56 (10), pp. 2497-2509. Date of Electronic Publication: 2021 May 14.
Zobrazit plný text záznamu
4
Akademický článek
Improved human islets' viability and functionality with mesenchymal stem cells and arg-gly-asp tripeptides supplementation of alginate micro-encapsulated islets in vitro.
Autor: Laporte C; Laboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U1055 and SFR Environmental and Systems Biology (BEeSy), University Grenoble Alps, Grenoble, France., Tubbs E; Laboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U1055 and SFR Environmental and Systems Biology (BEeSy), University Grenoble Alps, Grenoble, France. Electronic address: tubbsemily@gmail.com., Pierron M; Univ. Grenoble Alpes, CEA, LETI, Technologies for Healthcare and Biology Division, Microfluidic Systems and Bioengineering Lab, F-38000, Grenoble, France., Gallego A; Nanoimmunotech S.L, Vigo, Pontevedra, Spain., Moisan A; Cell Therapy and Engineering Unit, EFS, Auvergne Rhône Alps, Saint Ismier, France., Lamarche F; Laboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U1055 and SFR Environmental and Systems Biology (BEeSy), University Grenoble Alps, Grenoble, France., Lozano T; Nanoimmunotech S.L, Vigo, Pontevedra, Spain., Hernandez A; Nanoimmunotech S.L, Vigo, Pontevedra, Spain., Cottet-Rousselle C; Laboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U1055 and SFR Environmental and Systems Biology (BEeSy), University Grenoble Alps, Grenoble, France., Gauchez AS; Biology Institute, Grenoble Alps University Hospital, Grenoble, France., Persoons V; Cell Therapy and Engineering Unit, EFS, Auvergne Rhône Alps, Saint Ismier, France., Bottausci F; Univ. Grenoble Alpes, CEA, LETI, Technologies for Healthcare and Biology Division, Microfluidic Systems and Bioengineering Lab, F-38000, Grenoble, France., Fontelaye C; Univ. Grenoble Alpes, CEA, LETI, Technologies for Healthcare and Biology Division, Microfluidic Systems and Bioengineering Lab, F-38000, Grenoble, France., Boizot F; Univ. Grenoble Alpes, CEA, LETI, Technologies for Healthcare and Biology Division, Microfluidic Systems and Bioengineering Lab, F-38000, Grenoble, France., Lablanche S; Laboratory of Fundamental and Applied Bioenergetics (LBFA), INSERM U1055 and SFR Environmental and Systems Biology (BEeSy), University Grenoble Alps, Grenoble, France; Grenoble University Hospital, Grenoble, France., Rivera F; Univ. Grenoble Alpes, CEA, LETI, Technologies for Healthcare and Biology Division, Microfluidic Systems and Bioengineering Lab, F-38000, Grenoble, France.
Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Aug 06; Vol. 528 (4), pp. 650-657. Date of Electronic Publication: 2020 Jun 06.
Zobrazit plný text záznamu
5
Report
Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transfer.
Autor: Meunier M; Department of Hematology, CHU Grenoble Alpes, Grenoble, France. mmeunier2@chu-grenoble.fr.; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France. mmeunier2@chu-grenoble.fr., Guttin A; Grenoble Institut des Neurosciences, INSERM U836, Grenoble Alpes University, Grenoble, France., Ancelet S; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Laurin D; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Zannoni J; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Lefebvre C; Laboratoire de Génétique des hémopathies, CHU Grenoble Alpes, Grenoble, France., Tondeur S; Laboratoire de Génétique des hémopathies, CHU Grenoble Alpes, Grenoble, France., Persoons V; Unité de Thérapie et d'Ingénierie Cellulaire, EFS Auvergne Rhône Alpes et UF Génétique moléculaire et maladie héréditaire et oncologie, CHUGA, Grenoble, France., Pezet M; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Pernet-Gallay K; Grenoble Institut des Neurosciences, Plateforme de Microscopie électronique, Grenoble Alpes University, Grenoble, France., Chuffart F; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Rousseaux S; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Testard Q; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France.; Département de Génétique et Procréation, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.; Bioinformatics Unit, Eurofins Biomnis, Lyon, France., Thevenon J; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France.; Département de Génétique et Procréation, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France., Jouzier C; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Deleuze JF; Centre National de Génotypage, Institut de Génomique, Evry and Centre d'Etude du Polymorphisme Humain, 2 rue Gaston Crémieux, 91000, Paris, France., Laulagnier K; Grenoble Institut des Neurosciences, INSERM U836, Grenoble Alpes University, Grenoble, France., Sadoul R; Grenoble Institut des Neurosciences, INSERM U836, Grenoble Alpes University, Grenoble, France., Chatellard C; Grenoble Institut des Neurosciences, INSERM U836, Grenoble Alpes University, Grenoble, France., Hainaut P; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France., Polack B; Department of Hematology, CHU Grenoble Alpes, Grenoble, France., Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France., Issartel JP; Grenoble Institut des Neurosciences, INSERM U836, Grenoble Alpes University, Grenoble, France., Park S; Department of Hematology, CHU Grenoble Alpes, Grenoble, France. spark@chu-grenoble.fr.; CNRS UMR 5309, INSERM, U1209, Université Grenoble Alpes, Institute for Advanced Bioscience, 38700, Grenoble, France. spark@chu-grenoble.fr.
Publikováno v: Leukemia [Leukemia] 2020 Aug; Vol. 34 (8), pp. 2249-2253. Date of Electronic Publication: 2020 Feb 12.
Zobrazit plný text záznamu
6
Akademický článek
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Autor: Charles J; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Dermatology Department, Pôle Pluridisciplinaire de Médecine, CHU Grenoble Alpes, Grenoble, France., Chaperot L; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Hannani D; Immune checkpoint inhibitors, PDCline Pharma, Grenoble., Bruder Costa J; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Dermatology Department, Pôle Pluridisciplinaire de Médecine, CHU Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Templier I; Dermatology Department, Pôle Pluridisciplinaire de Médecine, CHU Grenoble Alpes, Grenoble, France., Trabelsi S; Dermatology Department, Pôle Pluridisciplinaire de Médecine, CHU Grenoble Alpes, Grenoble, France., Gil H; Pathology Department, Institut de Biologie et Pathologie, CHU Grenoble Alpes, Grenoble, France., Moisan A; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Cell Therapy and Engineering Unit, Etablissement Français du Sang Auvergne-Rhône-Alpes, Saint Ismier, France., Persoons V; Cell Therapy and Engineering Unit, Etablissement Français du Sang Auvergne-Rhône-Alpes, Saint Ismier, France., Hegelhofer H; Cell Therapy and Engineering Unit, Etablissement Français du Sang Auvergne-Rhône-Alpes, Saint Ismier, France., Schir E; Délégation à la Recherche Clinique et à l'Innovation, CHU Grenoble Alpes, Grenoble, France., Quesada JL; Centre d'investigation Clinique, CHU Grenoble Alpes, Grenoble, France., Mendoza C; Centre d'investigation Clinique, CHU Grenoble Alpes, Grenoble, France., Aspord C; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Manches O; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France., Coulie PG; de Duve Institute, Université Catholique de Louvain, Brussels, Belgium., Khammari A; Onco-dermatology Department, CHU Nantes, CIC 1413, CRCINA, Nantes University, Nantes, France., Dreno B; Onco-dermatology Department, CHU Nantes, CIC 1413, CRCINA, Nantes University, Nantes, France., Leccia MT; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; Dermatology Department, Pôle Pluridisciplinaire de Médecine, CHU Grenoble Alpes, Grenoble, France., Plumas J; Immunobiology and Immunotherapy of Chronic Diseases, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.; R&D Laboratory, Etablissement Français du Sang Auvergne-Rhône-Alpes, Grenoble, France.; Immune checkpoint inhibitors, PDCline Pharma, Grenoble.
Publikováno v: Oncoimmunology [Oncoimmunology] 2020 Apr 12; Vol. 9 (1), pp. 1738812. Date of Electronic Publication: 2020 Apr 12 (Print Publication: 2020).
Zobrazit plný text záznamu
7
Akademický článek
Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.
Autor: Filippova A; Laboratory of Virology, University Hospital of Grenoble, Grenoble, France; Irkutsk State Medical University, Ministry of Health of Russia, Irkutsk, Russia., Charles J; Dermatology Unit, Univ. Grenoble Alpes, IAB, University Hospital of Grenoble, Grenoble, France., Epaulard O; Infectious Diseases Department, University Hospital of Grenoble, Grenoble, France; Institut de Biologie Structurale, CEA, CNRS, Univ. Grenoble Alpes, Grenoble, France., Germi R; Laboratory of Virology, University Hospital of Grenoble, Grenoble, France; Institut de Biologie Structurale, CEA, CNRS, Univ. Grenoble Alpes, Grenoble, France., Persoons V; Cell therapy and engineering Unit, EFS Rhone Alpes, Saint-Ismier, France., Templier I; Dermatology Unit, Univ. Grenoble Alpes, IAB, University Hospital of Grenoble, Grenoble, France., Leccia MT; Dermatology Unit, Univ. Grenoble Alpes, IAB, University Hospital of Grenoble, Grenoble, France., Dreno B; Oncodermatology department, CIC, CHU, Nantes, France; Immunodermatology lab, CHU, Nantes, France; U 892, INSERM, Nantes, France., Malova I; Irkutsk State Medical University, Ministry of Health of Russia, Irkutsk, Russia., Morand P; Laboratory of Virology, University Hospital of Grenoble, Grenoble, France; Institut de Biologie Structurale, CEA, CNRS, Univ. Grenoble Alpes, Grenoble, France., Lupo J; Laboratory of Virology, University Hospital of Grenoble, Grenoble, France; Institut de Biologie Structurale, CEA, CNRS, Univ. Grenoble Alpes, Grenoble, France. Electronic address: jlupo@chu-grenoble.fr.
Publikováno v: Cytotherapy [Cytotherapy] 2018 Apr; Vol. 20 (4), pp. 521-523. Date of Electronic Publication: 2018 Feb 09.
Zobrazit plný text záznamu
8
Akademický článek
The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?
Autor: Hansen, Frederik J.1 (AUTHOR) frederik.hansen@fau.de, David, Paul1 (AUTHOR) paul.david@uk-erlangen.de, Weber, Georg F.1 (AUTHOR) paul.david@uk-erlangen.de
Publikováno v: Cancers. Jun2024, Vol. 16 Issue 12, p2216. 16p.
Zobrazit plný text záznamu
10
Akademický článek
The therapeutic potential of exosomes in lung cancer.
Autor: Liang, Hongyuan1 (AUTHOR), Zhang, Lingyun2 (AUTHOR), Zhao, Xiangxuan3 (AUTHOR) xiangxuanzhao@163.com, Rong, Jian4 (AUTHOR) iamrongjian@163.com
Publikováno v: Cellular Oncology (2211-3428). Oct2023, Vol. 46 Issue 5, p1181-1212. 32p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje